So a 200 million Dollar market cap will put us roughly at .10 cents. That will still be lower than the other two bio-techs you mentioned that have years left to go in clinical testing.
Amazing thing is ADMD doesn't have to wait years for clinical testing. For what would be the newest FDA approved Y-90 Modern day cutting edge cancer treatment I think the market cap would immediately grow to around 500 million dollars to 1 Billion Dollars which will be a PPS of roughly .25 to .50 cents for starters! Up-listing could come very quickly! What an amazing opportunity we have here with ADMD.
News 
Market Data 
Discover 
